BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Independence Blue Cross is launching a network to manage the cost and outcomes of gene-based therapies with Philadelphia-based Penn Medicine and Children's Hospital of Philadelphia, reports Becker’s Payer Issues. Gene-based therapies can treat rare genetic conditions but come with sky-high price tags. Independence Blue Cross is also pursuing outcome-based agreements with drug manufacturers for new gene-based drugs coming to market, the insurer said.
1. Hackers leak stolen data from Change Healthcare on dark web
2. Hacking group Ransomhub claims to have stolen UnitedHealth data
3. UnitedHealth estimates $1.6 billion loss from Change cyberattack
4. Ex-NBA player Will Bynum sentenced in insurance fraud scandal
5. Teladoc Health CEO Jason Gorevic steps down amid stock plunge
6. Biden administration limits Medicare Advantage broker compensation